Abstract
INTRODUCTION
D acryocystorhinostomy (DCR), first described by Toti [1] in 1904. In 1921, Dupuy-Dutemps and Bourget [2] , and later Falk [3] in 1961, improved rates of successful fistulization by directly suturing the edges of nasal and lacrimal sac mucosal flaps [4] . In 1982, silicone tube intubation has been improved by Older [5] . It gained popularity and became the standart surgical procedure for the treatment of nasolacrimal duct obstruction (NDO). Nowadays, it is the golden standart surgical procedure for NDO. Due to pre-and postoperative bleeding and longer procedure and recovery times and leaving facial scar of external dacryocystorhinostomy (EX-DCR), researchers and surgeons tried to find alternative techniques. The first endonasal DCR was performed by Caldwell [6] in 1893, and first laser assisted approach was described in 1990 by Massaro et al [7] . Different laser types have been used in DCR procedures: Holmium:Yttrium-Aluminum-Garnet (Ho:YAG) laser; Potassium-Tytanyl-Phosphate (PTP) laser; Neodymium:YAG (Nd:YAG) laser; Erbium:YAG (Er:YAG) and diode laser [4] . Diode laser-assisted DCR (L-DCR) was first reporterd by Eloy et al [8] in 2000. It used more and more because L-DCR had less tissue damage and sufficient osteotomy can be created using diode laser. The advantages of diode laser are; no external facial skin scar, local anesthesia possibility, less hemorrhage, fast procedure and minimal intra-and postoperative complications [4] . Although, L-DCR has several advantages, long term anatomical and functional success rate is remain unclear. The goal of this study is to evaluate the long term (5y) success rate of L-DCR in a selected patient group with acquired NDO.
SUBJECTS AND METHODS
This is a retrospective nonrandomized, noncomparative, nonrandomized, interventional study conducted by working on the data of 41 eyes of 40 consecutive patients with epiphora referred to the Department of Ophthalmology, Afyon Kocatepe University Hospital, Afyonkarahisar, Turkey. From September 2008 to March 2012, L-DCR was performed to all subjects using multidiode laser. The study was conducted in compliance with the principles of Declaration of Helsinki and approved by Afyonkarahisar Ethics Committee. All patients with a history of epiphora underwent preoperative full clinical ophtalmic examination (visual acuity, anterior segment examination, intraocular pressure, fundus examination). Lacrimal drainage system irrigation was performed with 26-gauge needle to determine any obstruction. The Ear, Nose and Throat (ENT) consultant examined the nasal cavity routinely. Dacryocystography was performed to all patients by applying approximately 0.5 mL contrast agent (Lipoidol Ultra fluide 480 mg/10 mL, Guerbet, France). Surgical Technique All surgeries were performed by the same surgeons (Güliz Fatma Yavaş, Tuncay Küsbeci). Nasal endoscopy was assisted during surgery by the same ENT specialist (Kahveci OK). Seven patients who had additional nasal abnormalities underwent surgery under general anestesia. The remaining 33 patients received local anesthesia. Preoperatively nasal decongestant spray (Iliadin, Santa Farma, Turkey) and lidocaine (Vemcaine Pump Sprey 10%, VEM Medicine, Turkey) was applied into the nasal cavity. Local anesthetic lidocaine hydrochloride 20 mg/mL+epinephrine 0.15 mg/mL (Jetokain, Adeka, Turkey) was administered using 30-gauge needle at three poits to achieve infraorbital, ethmoidal and medial canthal nerve blocks. After operative site antisepsis using povidone iodine 10%, the upper and lower canaliculi were dilated using Bowman probes. A rigid nasal endoscope with a 0-degree angle was inserted into the nose. Multidiode laser (Intermedical Multidiode S-30 OFT; Figure 1 ) was used. The settings were adjusted for each patient being at 10 W energy, 400ms pulse, 400ms pause and contact mode. The radius of the diode laser fiberoptic probe used was 600 µm. This probe was introduced into the lacrimal sac through the upper and lower canaliculi, until the transillumination of the aiming beam could be seen via the nasal endoscope just lateral and superior to the middle turbinate. Of 980 nm diode laser was applied until the largest possible osteotomy was achieved. The area of ostetomy was expanded to approximately 8-10 mm in diameter, and coagulated using diod-laser, carbonized tissue was removed under endoscopic guidance. Nasolacrimal passage was irrigated using 0.9% NaCl from both upper and lower punctums. In all subjects, bicanalicular intubation was performed. Totally 23-gauge silicone tube was then passed through the inferior and superior canaluculi, retreived from the nose, tied as a double knot and the knot was left inside the nose ( Figure 2 ). Postoperative medication consisted of nasal oximetasoline hydrochloride 0.05% sprey (Iliadin, Santa Farma, Turkey) 3 times a day for the first 2d followed by nasal triamcinolone 0.025% sprey (Nasacort AQ, Aventis, Turkey) 4 times a day for 1mo and topical tobramycin/dexametasone eye drops (Tobradex, Alcon Inc., USA) 4 times a day for 1mo. Follow-up time was 5y. Each patient examined at day 1, week 1, month 1, month 3 and then every 3mo for the first year. After the first year, follow-up was done 12 monthly till 5y. Lacrimal irrigation performed at every visit. The silicon tube removed at 3mo postoperatively. Functional success was defined as the disappearance of epiphora under normal conditions and the presence of patent ostium on lacrimal irrigation. Anatomical sucess was defined as a patent ostium on lacrimal irrigation besides continuing epiphora. Patients with persistent epiphora and closed ostium on lacrimal irrigation were defined as surgical failure. Statistical analysis was performed using IBM SPSS Version 22.0 (IBM Corp., Armok, NY, USA). RESULTS Forty-one eyes of forty patients were included in this study. Of 67.5% of patients (27 out of 40) were female and 32.5% of patients (13 out of 40) were male. Patients age ranged between 21-85y (mean 56.7y; Table 1 ). The NDO was right-sided in 17 (42.5%) patients and left-sided in 22 (55%) patients whereas 1 (2.5%) patient had undergone bilateral surgery. The surgery performed under general anestesia in 7 (17.5%) patients whereas 33 patients (83.5%) with local anesthesia. The mean power of used laser energy was 287±27.9 J (239-367 J). The mean procedure time was 26.50±4. 9min (16-39min) . Silicone tubes removed at postoperative month 3. At postoperative month 6, functional success was seen in 90% of subjects whereas at postoperative month 12 it was seen in 84% of subjects. At postoperative 60mo (5y), functional sucess was seen in 26 patients (65%), anatomical success was seen in 30 patients (75%). Surgical failure was seen in 10 (25%) subjects (Figure 3 ). There were no complications seen intraoperatively. Postoperatively, 1 (2.5%) patient had epistaxis, 1 (2.5%) patient had punctal slitting. Revision of surgery was performed in 10 cases (25%), failure after the revision surgery was seen in 2 cases (5%). There were additional nasal abnormalities in 11 (27.5%) patients. Three patients (7.5%) had concha hypertrophy, 6 patients (15%) had septum deviation, 1 patient (2.5%) had synechia and 1 patient (2.5%) had synechia with septum deviation. Among these patients, 8 of them had septoplasty and 2 of them underwent polip excision together with L-DCR. Three patients who had concha hypertropy were women, 2 of the patients who had septum deviation were women, and 2 patients who had synechy were women .When we analyzed all 27 women patients who underwent L-DCR, 3 (11.11%) had concha hypertrophy, 2 (7.4%) had septum deviation, and 2 (7.4%) had synechia. In men, 4 patients (30.77%) had septum deviation (Table 2) . DISCUSSSION Eloy et al [8] described the use of diode laser for endocanalicular laser DCR surgery in 2000 and reported a success rate of 58.6% (17 out of 29 patients) at postoperative month 6. Alañón Fernández et al [9] observed 43 patients undergoing transcanalicular DCR for 4-38mo, and reported a sucess rate of 90.7%. Failure was seen in 4 subjects where 2 patients (4.65%) had epiphora and permeable tract, 1 patient (2.2%) presented with lower canaliculi obstruction, and 1 patient showed total closing of osteotomy. In our study 1 (2.5%) patient had an epistaxis after surgery and 1 (2.5%) patient had punctal slitting after surgery which was compatible with the literature. Caversaccio et al [10] used erbium laser in transcanalicular DCR and reported 75% success in 2001. Gulati et al [11] evaluated the role of endoscopic endonasal DCR in pediatric population aged between 2-12y and reported a success rate of 85% at 6 months. Similarly, Marfatia et al [12] described 95.65% sucess rate in 21 pediatric patients. Nuhoglu et al [4] followed 42 patients undergoing L-DCR for 42mo and reported a long term sucess rate of 95.2%. Deng et al [13] reported a sucess rate of 96.0%
in subjects undergoing endoscopic DCR at 1-year follow-up. Coumou et al [14] evaluated subjects undergoing endoscopic DCR over a 14-year period from 1999 to 2014 retrospectively and found that adult DCR had an anatomical sucess of 90.1% whereas in children, anatomical success was 91.5%. In our study anatomical success at 6-month follow-up was 90%, at 12-month follow-up was 80%, at 36-month follow-up was 77% and at 60-month follow-up was was 75% of rate. Of 60-month rates in our study was not compatible to the studies was described before; it may cause of selection of age range in our study. The study of Lin et al [15] consisted of 53 consecutive patients who underwent revision endoscopic DCR between 2002 and 2013 for lacrimal duct obstruction. The aim of this study was to identify causes of previous DCR failure, and the authors compared patients whose initial surgery was performed through an external versus an endoscopic approach. They detected in this study that, surgical sucess rates for revision DCR surgery were comparable between the groups, with a mean follow-up of 12.7mo (75% external versus 73.3% endoscopic; P=0.90). Derya et al [16] compared the success rates of L-DCR and external DCR, and found a sucess rate of 68% in 25 cases undergoing L-DCR after a mean follow-up time of 7.12mo whereas the success rate in 29 patients undergoing external DCR was 86% with a mean follow-up time of 8.82mo. Though the success rate was higher in the EX-DCR group, it was reported to be statistically not significant (P=0.202). Mourya and Rijal [17] compared the efficacy of L-DCR with conventional EX-DCR; and found an overal sucess rate was 90.12% in patients who underwent L-DCR and 95.40% in patients who underwent conventional EX-DCR. Lee et al [18] reported in their retrospective study that the overall sucess rate of endoscopic endonasal DCR was 86.3% for at least 6mo observation. The study of Feijó et al [19] consisted of modified L-DCR where nasal mucosa was removed prior to laser osteotomy versus conventional L-DCR. In the case of modified DCR, the anatomical and functional sucess rates after 12mo were 90 and 86% respectively; whereas after conventional L-DCR, these rates were 77% and 72%, respectively. As the difference of success rates between these 2 methods was statistically not significant, they reported both procedures to be safe and fast with low morbidity.
In our study rate of anatomical success was 75%, functional success was 65% and surgical failure was 25%. These rates were lower than the success rates reported in the literature. We think that this can be related with the long follow-up time in our study. In the literature there are a few studies that observed patients for a long time period such as ours. The results of the study performed by Kaynak et al [20] are similar to our study. In this study they reported a functional sucess rate of 85.4% at postoperative month 3 that decreased to 67.7% at postoperative month 6, 63.3% at first year and 60.3% second year, while the patency of the lacrimal drainage was restored in 93.1%, 74.6%, 69.5%, and 68.2% of the cases, respectively. Also in the study of Plaza et al [21] there was no significant difference between 12mo and 36mo. Ajalooline et al [22] compared external transcanalicular DCR with L-DCR with amean follow-up of 18mo, and reported a success rate of 94.3% in the L-DCR group versus 92.7% in the EX-DCR group. In our study, the mean procedure time was 26.5min which was found to be compatible with the literature. Ajalooline et al [22] reported that the mean operation time was 19min for L-DCR whereas it was 61min for EX-DCR. Mourya et al [17] reported mean total surgical time to be 17.41min in L-DCR group and 49.49min in conventional EX-DCR group. Mean laser energy we used was 287 J (239 -367 J), which was consistent with the studies in the literature. DrnovsekOlup et al [23] reported an average of 245 J (195 to 685 J) of laser energy; Cintra et al [24] used 289 to 532 J (mean 392 J) of laser energy to create an ostium. Basmak et al [25] achieved an increase in surgical sucess (66%-86%) when the mean laser energy that was used during surgery was decreased from 300 to 165 J. In our study the silicone tubes was removed at 3 th month. This interval is consistent with the studies in the literature. Rebeiz et al [26] recommends the silicone tubes to be removed after at least 6wk. The suggestion of Häuse et al [27] is 6mo, because it creates the risk of fibrosis. The strength of our study is follow-up time. We followed patients up to 5y. Due to our best of knowledge, there is no other study that has 5y or more follow-up time.
The limitations of our study are, small sample size and lack of control group (no cases of endonasal endoscopic or EX-DCR). Due to our clinic's limited capacity, we could not operate and followed-up more patients.
In conclusion, transcanalicular L-DCR is known to have a shorter operative time and a relative lower complication rate. It has been increasingly utilized due to the advantages of faster rehabilitation, preservation of the lacrimal pump function, decreased invasiveness, and the absence of an external scar. The functional and anatomical success rate is higher in the first months and years, but still satisfactory at fifth year. But, further long term comparative studies are required to clarify the effectiveness of multidiode L-DCR in patients with NDO. 
